Search
Search Funnelback University
- Refined by:
- Date: 2022
71 -
90 of
230
search results for `news stories`
Fully-matching results
-
Rat IgG2b monoclonal antibody NORIg 7.16.2
https://www.enterprise.cam.ac.uk/reagents/rat-igg2b-monoclonal-antibody-norig-7-16-2/9 May 2022: Hybridoma cell line against rat IgG2b, producing NORIg 7.16.2 antibodies which are mouse monoclonal antibodies.
-
Mouse CD18 monoclonal antibody YTS 213.1.1
https://www.enterprise.cam.ac.uk/reagents/mouse-cd18-monoclonal-antibody-yts-213-1-1/9 May 2022: Hybridoma cell line producing YTS 213.1.1 antibodies raised against mouse CD18 which are rat monoclonal antibodies of the IgG2a isotype.
-
FcgRIIIa 158F/GPI receptor expressing cell line
https://www.enterprise.cam.ac.uk/reagents/fcgriiia-158fgpi-receptor-expressing-cell-line/9 May 2022: CHO cells transfected to express human FcgRIIIa of the 158F allotype on their surface as glycosyl-phosphatidylinositol-anchored molecules.
-
FcgRIIIa 158V/GPI receptor expressing cell line
https://www.enterprise.cam.ac.uk/reagents/fcgriiia-158vgpi-receptor-expressing-cell-line/9 May 2022: CHO cells transfected to express human FcgRIIIa of the 158V allotype on their surface as glycosyl-phosphatidylinositol-anchored molecules.
-
KARPAS 45 Human T-cell Leukaemia cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-45-human-t-cell-leukaemia-cell-line/9 May 2022: KARPAS 45 Human T-cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.
-
KARPAS 353 Human B-cell Leukaemia cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-353-human-b-cell-leukaemia-cell-line/9 May 2022: KARPAS 353 Human B-cell Leukaemia cell line useful in oncology research, developed at the University of Cambridge.
-
KARPAS 231 Human B-cell Leukaemia cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-231-human-b-cell-leukaemia-cell-line/9 May 2022: KARPAS 231 Human B-cell Leukaemia cell line useful in oncology research, developed at the University of Cambridge.
-
Impact Insight video case study: Versed AI – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-versed-ai/15 Mar 2022: The second in our new series of Impact Insight videos focuses on the exciting research commercialisation story behind Versed AI.
-
Mouse Thy-1 monoclonal antibody YBM 29.2.1
https://www.enterprise.cam.ac.uk/reagents/mouse-thy-1-monoclonal-antibody-ybm-29-2-1/9 May 2022: Hybridoma cell line producing YBM 29.2.1antibodies raised against mouse Thy-1, which are rat monoclonal antibodies of the IgG2c isotype.
-
Sharp graphite tips for nanotechnology applications – Cambridge…
https://www.enterprise.cam.ac.uk/reagents/sharp-graphite-tips-for-nanotechnology-applications/9 May 2022: Sharp graphite tips have been developed in the lab of Dr Amalio Fernandez-Pacheco at the University of Cambridge using a three-step polishing method.
-
Tetrabutylammonium…
https://www.enterprise.cam.ac.uk/reagents/tetrabutylammonium-4methyl-22bipyridin-5ylmethanesulfonate/9 May 2022: Tetrabutylammonium (4'methyl-[2,2'bipyridin]-5yl)methanesulfonate is a ligand for iridium to control regioselectivity of iridium-catalysed borylation
-
Sheep immunoglobulin G monoclonal antibody SIg 375
https://www.enterprise.cam.ac.uk/reagents/sheep-immunoglobulin-g-monoclonal-antibody-sig-375/9 May 2022: Hybridoma cell line producing SIg 375 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.
-
Sheep immunoglobulin G monoclonal antibody SIg 482
https://www.enterprise.cam.ac.uk/reagents/sheep-immunoglobulin-g-monoclonal-antibody-sig-482/9 May 2022: Hybridoma cell line producing SIg 482 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.
-
Sheep immunoglobulin G monoclonal antibody SIg 743
https://www.enterprise.cam.ac.uk/reagents/sheep-immunoglobulin-g-monoclonal-antibody-sig-743/9 May 2022: Hybridoma cell line producing SIg 743 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.
-
petermr's blog | A Scientist and the Web | Page 197
https://blogs.ch.cam.ac.uk/pmr/page/197/17 Jan 2022: synthetic methods and critical reaction data. — patents, journals and news stories that feature the compound. — ... patents, journals and news stories that feature the compound (patent information is generally made Open by the patent offices – PMR). -
Nyobolt: Supercharging the electric revolution – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/nyobolt-supercharging-the-electric-revolution/11 Apr 2022: Nyobolt is a University spin out from the Yusuf Hamied Department of Chemistry, commercialising a novel ultra-high power battery technology
-
The Chris Abell Postdoc Business Plan Competition 2022 – Cambridge…
https://www.enterprise.cam.ac.uk/events/the-chris-abell-postdoc-business-plan-competition-2022/3 May 2022: The Chris Abell Postdoc Business Plan Competition is a programme designed to help accelerate the creation of businesses from University research.
-
KARPAS 620 Human Plasma Cell Leukaemia cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-620-human-plasma-cell-leukaemia-cell-line/9 May 2022: KARPAS 620 Human Plasma Cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.
-
Human HLA-class I monoclonal antibody YTH 862.2
https://www.enterprise.cam.ac.uk/reagents/human-hla-class-i-monoclonal-antibody-yth-862-2/9 May 2022: Hybridoma cell line producing YTH 862.2 antibodies raised against human HLA-class I which are rat monoclonal antibodies of the IgG2b isotype.
-
Human insulin receptor monoclonal antibody IR CT-1
https://www.enterprise.cam.ac.uk/reagents/human-insulin-receptor-monoclonal-antibody-ir-ct-1/9 May 2022: Hybridoma cell line producing IR CT-1 antibodies against the C-terminal portion of the human insulin receptor beta subunit, which are of the IgG1 isotype.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.